Effects of GRIN2B, GRIA1, and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial : Clinical Neuropharmacology

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Original Articles

Effects of GRIN2B, GRIA1, and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial

Beanes, Graziele DDS∗,†; Caliman-Fontes, Ana Teresa MD; Souza-Marques, Breno BScPsy∗,†; Silva, Hátilla Dos Santos BScBio; Leal, Gustavo C. DDS∗,†; Carneiro, Beatriz Alves BScBio∗,†; Guerreiro-Costa, Lívia N.F. DDS∗,†; Figueiredo, Alexandre V. MD; Figueiredo, Camila Alexandrina V. PhD; Lacerda, Acioly L.T. PhD§,∥; Costa, Ryan dos S. PhD; Quarantini, Lucas C. PhD∗,†

Author Information
doi: 10.1097/WNF.0000000000000517
  • Buy
  • SDC

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.